Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors

被引：12

作者：

Hyman, D. ^{[1
]}

Chatterjee, M. ^{[2
]}

Langenberg, M. H. G. ^{[3
]}

Lin, C. C. ^{[4
]}

Suarez, C. ^{[5
,6
]}

Tai, D. ^{[7
]}

Cassier, P. ^{[8
]}

Yamamoto, N. ^{[9
]}

De Weger, V. A. ^{[10
]}

Jeay, S. ^{[11
]}

Meille, C. ^{[12
]}

Halilovic, E. ^{[13
]}

Mariconti, L. ^{[12
]}

Guerreiro, N. ^{[12
]}

Kumar, A. ^{[14
]}

Wuerthner, J. U. ^{[12
]}

Bauer, S. ^{[15
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

[2] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[3] UMC Utrecht Canc Ctr, Dept Med Oncol, Utrecht, Netherlands

[4] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[5] Vall dHebron Univ Hosp, Barcelona, Spain

[6] Univ Autonoma Barcelona, Dept Med Oncol, Inst Oncol, Barcelona, Spain

[7] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore

[8] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[9] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan

[10] Netherlands Canc Inst, Dept Clin Pharmacol, Amsterdam, Netherlands

[11] Novartis Pharma AG, Dept Oncol Res, Basel, Switzerland

[12] Novartis Pharma AG, Dept Translat Clin Oncol, Basel, Switzerland

[13] Novartis Inst BioMed Res, Dept Translat Clin Oncol, Cambridge, MA USA

[14] Novartis Healthcare Private Ltd, Dept Oncol Global Dev, Hyderabad, Andhra Pradesh, India

[15] Univ Duisburg Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany

来源：

EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷

关键词：

D O I：

10.1016/S0959-8049(16)32982-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

391

引用

页码：S128 / S129

页数：2